Clinical Trial to Evaluate the Efficacy and Safety of CKD-342
NCT02498509 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 459
Last updated 2016-12-26
Summary
Clinical Trial to Evaluate the Efficacy and Safety of CKD-342
Conditions
- Rhinitis, Allergic, Perennial
Interventions
- DRUG
-
CKD-342
treatment for 4 weeks after randomization
- DRUG
-
Mometasone furoate
treatment for 4 weeks after randomization
- DRUG
-
Levocabastine HCL
treatment for 4 weeks after randomization
Sponsors & Collaborators
-
Chong Kun Dang Pharmaceutical
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 13 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-05-31
- Primary Completion
- 2016-03-31
- Completion
- 2016-05-31
Countries
- South Korea
Study Locations
More Related Trials
-
A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen
NCT00291642 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites
NCT00521131 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis
NCT06577077 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Mometasone Furoate Plus Azelastine HCl Combination Versus Mometasone Furoate Alone or Azelastine Alone in Patients With Perennial Allergic Rhinitis
NCT01470053 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients
NCT03570957 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR
NCT00521040 ·Status: COMPLETED ·Phase: NA
-
Concomitant Intranasal Antihistamine and Corticosteroid in Stepwise Treatment Strategy for Allergic Rhinitis
NCT05708157 ·Status: UNKNOWN
-
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
NCT02125253 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis
NCT00621959 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean
NCT01982916 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic Rhinitis
NCT05311475 ·Status: COMPLETED ·Phase: PHASE3
-
Allergen Challenge Trial of IRL201104 in Seasonal Allergic Rhinitis
NCT05098522 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate Adenosine Monophosphate and Allergen Challenge in Allergic Rhinitis
NCT00679250 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects
NCT00544388 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study in Allergic Rhinitis Patients After Intranasal Administration of AZD8848
NCT01185080 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of Mometasone Nasal Spray, Nasonex Nasal Spray, Nasonex Nasal Spray Suspension, & Placebo for Treatment of Seasonal Allergies for Safety, Efficacy, & Superiority in 1520 Male & Female Volunteers
NCT02109185 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma
NCT00044824 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Evaluation of Safety and Immune Activity of New Immunotherapeutic Agents for HDM Allergic Rhinitis Patients
NCT05525650 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis
NCT00263549 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic Rhinitis
NCT01160861 ·Status: COMPLETED ·Phase: PHASE1
-
A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR)
NCT01957202 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of DEP114 in the Treatment of Moderate to Severe Persistent Allergic Rhinitis in Children.
NCT06272409 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients
NCT03655210 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
NCT01038427 ·Status: COMPLETED ·Phase: PHASE3
-
Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen
NCT00315523 ·Status: COMPLETED ·Phase: PHASE3